Vemurafenib (V) in BRAF V600E metastatic melanoma (mM): Analysis of 507 patients (pts) enrolled in the French temporary authorization for use (ATU)

被引：0

作者：

Lebbe, Celeste

Robert, Caroline

Dreno, Brigitte

Thomas, Luc

Grob, Jean Jacques

Meyer, Nicolas

Regnier-Rosencher, Elodie

Saiag, Philippe

Mortier, Laurent

Hospital, Valerie

Duval-Modeste, Anne Benedicte

Dalac-Rat, Sophie

Lesimple, Thierry

Guillot, Bernard

Leccia, Marie Therese

Bitoun, Laurence

Bobadilla, Luz

Jouary, Thomas

机构：

[1] St Louis Hosp, Paris, France

[2] Inst Gustave Roussy, Villejuif, France

[3] CHU Nantes, Hotel Dieu, F-44035 Nantes 01, France

[4] Univ Lyon 1, F-69365 Lyon, France

[5] Aix Marseille Univ, Timone Hosp, Dept Dermatol, Marseille, France

[6] Hop Larrey, CHU Toulouse, Toulouse, France

[7] Hop Cochin, F-75674 Paris, France

[8] Univ Versailles SQY, Hosp Ambroise Pare, APHP, Boulogne, France

[9] CHRU Lille, Dermatol Clin, Lille, France

[10] CHU Clermont Ferrand, Clermont Ferrand, France

[11] CHU Rouen, Rouen, France

[12] CHU Dijon, Dijon, France

[13] Ctr Eugene Marquis, Rennes, France

[14] CHU Montpellier, Montpellier, France

[15] Univ Hosp Grenoble, Grenoble, France

[16] Roche, Boulogne Billancourt, France

[17] Univ Hosp Bordeaux St Andre, Bordeaux, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8591

引用

页数：1